title: A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder.
abstract: The anticonvulsant drug lamotrigine (LTG), a sodium channel blocker and inhibitor of glutamate release, has been found to have antidepressant effects in the treatment of bipolar disorder. It is recommended by certain therapy guidelines as a first-line agent for acute and maintenance therapy in bipolar depression, but there have been only some promising results of placebo-controlled trials on its acute antidepressant effects, and the recommendation in therapy guidelines has been reconsidered. On the contrary, positive results for maintenance therapy could be confirmed, and LTG is still a well-tolerated option, especially in patients with predominant depressive episodes. Antimanic effects are not shown in the literature, and its use is not advised in any guidelines that were examined. In conclusion, the findings of the present review article on treatment guidelines for bipolar disorder question the role of LTG in acute depressive states, and critically discusses its use, particularly in acute depressive states.
authors: Department of Psychiatry and Psychotherapy, University Hospital Leipzig, Leipzig, Germany.
authors: Anja
authors: A
authors: Tränkner
authors: Christian
authors: C
authors: Sander
authors: Peter
authors: P
authors: Schönknecht
keywords: bipolar depression; bipolar disorder; lamotrigine
references: Ann Pharmacother. 2002 May;36(5):860-73
references: 11978166
references: Bipolar Disord. 2011 Feb;13(1):111-7
references: 21320258
references: J Psychopharmacol. 2011 Oct;25(10):1289-94
references: 20823080
references: J Clin Psychiatry. 1997 Dec;58(12):522-7
references: 9448654
references: J Affect Disord. 2008 Dec;111(2-3):334-43
references: 18358540
references: J Clin Psychiatry. 2007 Jun;68(6):973-4
references: 17592931
references: Bipolar Disord. 2007 Sep;9(6):551-60
references: 17845269
references: J Clin Psychiatry. 1999 Feb;60(2):79-88
references: 10084633
references: Biol Psychiatry. 1999 Apr 15;45(8):953-8
references: 10386176
references: J Clin Psychiatry. 2006 Jul;67(7):1025-33
references: 16889444
references: Singapore Med J. 2011 Dec;52(12):914-8; quiz 919
references: 22159936
references: Bipolar Disord. 2009 May;11(3):225-55
references: 19419382
references: World J Biol Psychiatry. 2010 Mar;11(2):81-109
references: 20148751
references: Arch Gen Psychiatry. 2003 Apr;60(4):392-400
references: 12695317
references: World J Biol Psychiatry. 2003 Jan;4(1):5-13
references: 12582971
references: Drugs. 1995 Oct;50(4):691-713
references: 8536554
references: J Clin Psychopharmacol. 2000 Dec;20(6):607-14
references: 11106131
references: Am J Psychiatry. 1997 Aug;154(8):1171-2
references: 9247416
references: Ann Clin Psychiatry. 2000 Mar;12(1):5-10
references: 10798820
references: J Clin Psychiatry. 2009 Feb;70(2):223-31
references: 19200421
references: Control Clin Trials. 1996 Feb;17(1):1-12
references: 8721797
references: World J Biol Psychiatry. 2004 Jul;5(3):120-35
references: 15346536
references: World J Biol Psychiatry. 2009;10(2):85-116
references: 19347775
references: Neuropsychopharmacology. 2011 Jan;36(2):375-89
references: 20980991
references: Acta Psychiatr Scand. 2007 May;115(5):360-5
references: 17430413
references: J Affect Disord. 2002 May;69(1-3):1-14
references: 12103447
references: Int J Neuropsychopharmacol. 2009 Jul;12(6):773-82
references: 19079815
references: J Affect Disord. 2006 Nov;96(1-2):95-9
references: 16820213
references: World J Biol Psychiatry. 2002 Jul;3(3):115-24
references: 12478876
references: J Psychiatr Pract. 2006 Sep;12(5):300-5
references: 16998417
references: J Affect Disord. 2008 Nov;111(1):100-5
references: 18314200
references: J Clin Psychiatry. 2008 Apr;69(4):609-16
references: 18294024
references: Am J Psychiatry. 2006 Feb;163(2):210-6
references: 16449473
references: Bipolar Disord. 2000 Dec;2(4):336-9
references: 11252647
references: Neuropsychiatr Dis Treat. 2008 Feb;4(1):227-34
references: 18728802
references: Bipolar Disord. 2006 Jun;8(3):289-93
references: 16696832
references: Lancet. 2011 Oct 8;378(9799):1306-15
references: 21851976
references: Br J Psychiatry. 2009 Jan;194(1):4-9
references: 19118318
references: Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1322-6
references: 20673782
references: Arch Gen Psychiatry. 2011 Mar;68(3):241-51
references: 21383262
references: J Clin Psychiatry. 2011 Mar;72(3):356-66
references: 20816033
references: Pharmacopsychiatry. 1996 Sep;29(5):193-5
references: 8895945
references: Eur Psychiatry. 2005 Mar;20(2):92-5
references: 15797691
references: Am J Psychiatry. 1999 Jul;156(7):1019-23
references: 10401445
references: J Clin Psychiatry. 2009 Sep;70(9):1273-80
references: 19689918
references: Clin Neuropharmacol. 2011 Jan-Feb;34(1):39-47
references: 21242744
references: Evid Based Ment Health. 2007 Feb;10(1):12
references: 17255381
references: Hum Psychopharmacol. 2009 Mar;24(2):145-52
references: 19132712
references: CNS Spectr. 2006 Sep;11(9):711-6; quiz 719
references: 16946696
references: Am J Psychiatry. 2006 Jul;163(7):1199-201
references: 16816224
references: Biol Psychiatry. 2002 Feb 1;51(3):253-60
references: 11839368
references: J Clin Psychiatry. 2006 Mar;67(3):400-6
references: 16649826
references: J Psychopharmacol. 2009 Jun;23(4):346-88
references: 19329543
references: J Clin Psychiatry. 2000 Nov;61(11):841-50
references: 11105737
references: Nervenarzt. 2012 May;83(5):568-86
references: 22576049
references: Drugs. 2003;63(19):2029-50
references: 12962521
references: Bipolar Disord. 2008 Mar;10(2):323-33
references: 18271912
references: Bipolar Disord. 2010 Aug;12(5):483-93
references: 20712749
references: J Clin Psychiatry. 2003 Sep;64(9):1013-24
references: 14628976
references: Psychother Psychosom. 2005;74(1):10-6
references: 15627851
references: Behav Brain Res. 2008 Aug 5;191(1):49-54
references: 18433891
references: J Clin Psychiatry. 2004 Mar;65(3):432-41
references: 15096085